Recent approaches for the synthesis of modified cryptophycins

Weiss C, Sammet B, Sewald N (2013)
Natural Product Reports 30(7): 924-940.

Journal Article | Published | English

No fulltext has been uploaded

Author
Abstract
Cryptophycins are a family of antimitotic depsipeptides with very high cytotoxicity even against multi-drug resistant (MDR) cancer cells. The first representative was isolated from cyanobacteria Nostoc sp. in 1990. Their bioactivity is based on their interaction with the protein tubulin. Cryptophycins were found to induce apoptosis due to inhibition of the microtubule dynamics. Consequently, cryptophycin analogues are considered as potential antitumour agents. Retrosynthetically, cryptophycins can be subdivided into four building blocks, namely units A-D, to be assembled in the total synthesis. Since the discovery of this compound class, numerous synthetic analogues have been designed for structure-activity relationship (SAR) studies. This review gives a critical overview on cryptophycins, while the main focus lies on the synthetic challenges of recently published cryptophycins, together with emerging concepts on cryptophycin bioconjugation and prodrug design.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Weiss C, Sammet B, Sewald N. Recent approaches for the synthesis of modified cryptophycins. Natural Product Reports. 2013;30(7):924-940.
Weiss, C., Sammet, B., & Sewald, N. (2013). Recent approaches for the synthesis of modified cryptophycins. Natural Product Reports, 30(7), 924-940.
Weiss, C., Sammet, B., and Sewald, N. (2013). Recent approaches for the synthesis of modified cryptophycins. Natural Product Reports 30, 924-940.
Weiss, C., Sammet, B., & Sewald, N., 2013. Recent approaches for the synthesis of modified cryptophycins. Natural Product Reports, 30(7), p 924-940.
C. Weiss, B. Sammet, and N. Sewald, “Recent approaches for the synthesis of modified cryptophycins”, Natural Product Reports, vol. 30, 2013, pp. 924-940.
Weiss, C., Sammet, B., Sewald, N.: Recent approaches for the synthesis of modified cryptophycins. Natural Product Reports. 30, 924-940 (2013).
Weiss, Christine, Sammet, Benedikt, and Sewald, Norbert. “Recent approaches for the synthesis of modified cryptophycins”. Natural Product Reports 30.7 (2013): 924-940.
This data publication is cited in the following publications:
This publication cites the following data publications:

4 Citations in Europe PMC

Data provided by Europe PubMed Central.

Cyanobacterial Metabolite Calothrixins: Recent Advances in Synthesis and Biological Evaluation.
Xu S, Nijampatnam B, Dutta S, Velu SE., Mar Drugs 14(1), 2016
PMID: 26771620
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?
Fanale D, Bronte G, Passiglia F, Calo V, Castiglia M, Di Piazza F, Barraco N, Cangemi A, Catarella MT, Insalaco L, Listi A, Maragliano R, Massihnia D, Perez A, Toia F, Cicero G, Bazan V., Anal Cell Pathol (Amst) 2015(), 2015
PMID: 26484003
Design and synthesis of a new class of cryptophycins based tubulin inhibitors.
Kumar A, Kumar M, Sharma S, Guru SK, Bhushan S, Shah BA., Eur J Med Chem 93(), 2015
PMID: 25647428
The vinylogous Mukaiyama aldol reaction (VMAR) in natural product synthesis.
Kalesse M, Cordes M, Symkenberg G, Lu HH., Nat Prod Rep 31(4), 2014
PMID: 24595879

71 References

Data provided by Europe PubMed Central.

3-Substituted indolizine-1-carbonitrile derivatives as phosphatase inhibitors.
Weide T, Arve L, Prinz H, Waldmann H, Kessler H., Bioorg. Med. Chem. Lett. 16(1), 2006
PMID: 16236508
Stereospecific synthesis of cryptophycin 1.
Li LH, Tius MA., Org. Lett. 4(10), 2002
PMID: 12000261

Eißler, Chem.–Eur. J. 15(), 2009

Tripathy, Tetrahedron Lett. 45(), 2004

Mast, Chem.–Eur. J. 11(), 2005
Total synthesis of cryptophycin-24 (Arenastatin A) amenable to structural modifications in the C16 side chain.
Eggen M, Mossman CJ, Buck SB, Nair SK, Bhat L, Ali SM, Reiff EA, Boge TC, Georg GI., J. Org. Chem. 65(23), 2000
PMID: 11073583
Synthesis of cryptophycin 52 using the Shi epoxidation.
Hoard DW, Moher ED, Martinelli MJ, Norman BH., Org. Lett. 4(10), 2002
PMID: 12000306

Fray, Tetrahedron: Asymmetry 9(), 1998
Total Synthesis of Cryptophycins via a Chemoenzymatic Approach.
Salamonczyk GM, Han K, Guo Zw , Sih CJ., J. Org. Chem. 61(20), 1996
PMID: 11667584

Kolb, Tetrahedron 48(), 1992

Sammet, Synlett (), 2009

Bolduc, Chem. Commun. 48(), 2012
Biological evaluation of cryptophycin 52 fragment A analogues: effect of the multidrug resistance ATP binding cassette transporters on antitumor activity.
Al-Awar RS, Corbett TH, Ray JE, Polin L, Kennedy JH, Wagner MM, Williams DC., Mol. Cancer Ther. 3(9), 2004
PMID: 15367700

Stoncius, Synthesis (), 2005
Total synthesis and biological evaluation of fluorinated cryptophycins.
Weiß C, Bogner T, Sammet B, Sewald N., Beilstein J Org Chem 8(), 2012
PMID: 23209540
Chemoenzymatic synthesis of cryptophycin anticancer agents by an ester bond-forming non-ribosomal peptide synthetase module.
Ding Y, Rath CM, Bolduc KL, Hakansson K, Sherman DH., J. Am. Chem. Soc. 133(37), 2011
PMID: 21823639

Haubner, Angew. Chem., Int. Ed. Engl. 36(), 1997
Antitumor activity of cryptophycins: effect of infusion time and combination studies.
Menon K, Alvarez E, Forler P, Phares V, Amsrud T, Shih C, Al-Awar R, Teicher BA., Cancer Chemother. Pharmacol. 46(2), 2000
PMID: 10972484

Sammet, Pharm. Pat. Analyst 1(), 2012

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 23732943
PubMed | Europe PMC

Search this title in

Google Scholar